Atlas Trials

Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer

Clinical trial NCT05669586 · UNKNOWN

Trial details

NCT number
NCT05669586
Sponsor
Affiliated Hospital of Jiangnan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung CancerOrganoid
Start date
2023-02-01
Primary completion
2024-05-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.